KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496,176 | +299.0% | 51,524 | +180.1% | 0.00% | – |
| Q4 2022 | $124,357 | -90.6% | 18,396 | -86.2% | 0.00% | -100.0% |
| Q2 2022 | $1,316,000 | +145.5% | 133,687 | +267.7% | 0.00% | +200.0% |
| Q1 2022 | $536,000 | +31.7% | 36,359 | +113.9% | 0.00% | -50.0% |
| Q2 2021 | $407,000 | -57.7% | 16,996 | -54.6% | 0.00% | -50.0% |
| Q1 2021 | $962,000 | +582.3% | 37,443 | +102.9% | 0.00% | +300.0% |
| Q1 2020 | $141,000 | -91.6% | 18,454 | -68.7% | 0.00% | -87.5% |
| Q1 2019 | $1,686,000 | – | 58,904 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |